These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35243012)

  • 1. R-etodolac is a more potent Wnt signaling inhibitor than enantiomer, S-etodolac.
    Roberts JS; Ma C; Robertson SYT; Kang S; Han CS; Deng SX; Zheng JJ
    Biochem Biophys Rep; 2022 Jul; 30():101231. PubMed ID: 35243012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of etodolac enantiomers in the rat. Lack of pharmacokinetic interaction between enantiomers.
    Brocks DR; Jamali F
    Drug Metab Dispos; 1990; 18(4):471-5. PubMed ID: 1976070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective HPLC-DAD method for the determination of etodolac enantiomers in tablets, human plasma and application to comparative pharmacokinetic study of both enantiomers after a single oral dose to twelve healthy volunteers.
    Hewala II; Moneeb MS; Elmongy HA; Wahbi AA
    Talanta; 2014 Dec; 130():506-17. PubMed ID: 25159440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enantiomers of etodolac, a racemic anti-inflammatory agent, play different roles in efficacy and gastrointestinal safety.
    Inoue N; Nogawa M; Ito S; Tajima K; Kume S; Kyoi T
    Biol Pharm Bull; 2011; 34(5):655-9. PubMed ID: 21532152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etodolac clinical pharmacokinetics.
    Brocks DR; Jamali F
    Clin Pharmacokinet; 1994 Apr; 26(4):259-74. PubMed ID: 8013160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of flurbiprofen, ketoprofen and etodolac enantiomers by pre-column derivatization RP-HPLC and application to drug-protein binding in human plasma.
    Jin YX; Tang YH; Zeng S
    J Pharm Biomed Anal; 2008 Apr; 46(5):953-8. PubMed ID: 18329215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of R- and S-enantiomers of chiral non-steroidal anti-inflammatory drugs in experimental colitis.
    Reuter BK; Mauleón D; Wallace JL
    J Gastroenterol Hepatol; 1998 Nov; 13(S3):S266-S269. PubMed ID: 28976674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an Enantioselective and Biomarker-Informed Translational Population Pharmacokinetic/Pharmacodynamic Model for Etodolac.
    de Miranda Silva C; Rocha A; Tozatto E; da Silva LM; Donadi EA; Dalla Costa T; Lanchote VL; Schmidt S; Bulitta JB
    AAPS J; 2017 Nov; 19(6):1814-1825. PubMed ID: 28875479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective disposition of etodolac enantiomers in synovial fluid.
    Brocks DR; Jamali F; Russell AS
    J Clin Pharmacol; 1991 Aug; 31(8):741-6. PubMed ID: 1831817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chiral bioequivalence: effect of absorption rate on racemic etodolac.
    Boni JR; Korth-Bradley JM; Richards LS; Chiang ST; Hicks DR; Benet LZ
    Clin Pharmacokinet; 2000 Dec; 39(6):459-69. PubMed ID: 11192477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells.
    Behari J; Zeng G; Otruba W; Thompson MD; Muller P; Micsenyi A; Sekhon SS; Leoni L; Monga SP
    J Hepatol; 2007 May; 46(5):849-57. PubMed ID: 17275129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stereoselective pharmacokinetics of etodolac in young and elderly subjects, and after cholecystectomy.
    Brocks DR; Jamali F; Russell AS; Skeith KJ
    J Clin Pharmacol; 1992 Nov; 32(11):982-9. PubMed ID: 1474171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin binding sites for etodolac enantiomers.
    Mignot I; Presle N; Lapicque F; Monot C; Dropsy R; Netter P
    Chirality; 1996; 8(3):271-80. PubMed ID: 8777148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of etodolac enantiomers in the rat after administration of phenobarbital or cimetidine.
    Brocks DR; Jamali F
    Eur J Drug Metab Pharmacokinet; 1992; 17(4):293-9. PubMed ID: 1301359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a stereospecific high-performance liquid chromatography assay to a pharmacokinetic study of etodolac enantiomers in humans.
    Jamali F; Mehvar R; Lemko C; Eradiri O
    J Pharm Sci; 1988 Nov; 77(11):963-6. PubMed ID: 2976091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chiral non-steroidal anti-inflammatory drugs--a review.
    Hardikar MS
    J Indian Med Assoc; 2008 Sep; 106(9):615-8, 622, 624. PubMed ID: 19552094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantioselective analysis of etodolac in human plasma by LC-MS/MS: Application to clinical pharmacokinetics.
    de Miranda Silva C; Rocha A; Tozatto E; da Silva LM; Donadi EA; Lanchote VL
    J Pharm Biomed Anal; 2016 Feb; 120():120-6. PubMed ID: 26723001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic difference between S-(+)- and R-(-)-etodolac in rats.
    Shi JM; Lai SG; Xu CJ; Duan GL; Li D
    Acta Pharmacol Sin; 2004 Aug; 25(8):996-9. PubMed ID: 15301730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparative resolution of etodolac enantiomers by preferential crystallization method.
    Dung PT; Trung TQ; Kim KH
    Arch Pharm Res; 2009 Oct; 32(10):1425-31. PubMed ID: 19898806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R-etodolac induces E-cadherin and suppresses colitis-related mouse colon tumorigenesis.
    Inoue T; Murano M; Yoda Y; Kuramoto T; Kakimoto K; Ishida K; Kawakami K; Abe Y; Morita E; Murano N; Tokioka S; Maemura K; Umegaki E; Higuchi K
    Oncol Rep; 2010 Dec; 24(6):1487-92. PubMed ID: 21042743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.